In early April 2026, RBC Capital Markets reported that Hanover Insurance Group’s earnings growth is likely to slow, with 2025 expected to be the peak through 2027 as catastrophe losses normalize, pricing spreads moderate, and macroeconomic uncertainty weighs on the outlook.
An interesting aspect of the report is management’s continued conservative reserving stance in challenging areas like Commercial Auto Liability, which may influence how investors assess future risk and capital...
If you are wondering whether Universal Technical Institute at around US$36.29 is priced for opportunity or already reflects the story you are buying into, this article walks through what the current valuation is actually indicating.
The stock has returned 0.5% over the last 7 days, 3.7% over the last 30 days and 46.1% year to date, with a 39.1% return over the last year and a very large gain over 5 years.
Recent coverage around Universal Technical Institute has focused on its role in the...
Why Maggie and the T-Mobile tie-up matter for Serve Robotics (NasdaqCM:SERV)
Serve Robotics (NasdaqCM:SERV) is back in focus after unveiling “Maggie,” its first AI-powered conversational robot, at NVIDIA GTC 2026, alongside a new collaboration with T-Mobile built around 5G Advanced and edge computing.
See our latest analysis for Serve Robotics.
Despite the excitement around Maggie and new partnerships, the stock’s 1-month share price return of 14.94% and 90-day share price return of 40.39%...
Wondering whether U-Haul Holding is a bargain or a value trap at around US$48.76? This breakdown will help you size up the stock with a clear valuation lens.
The share price has moved 2.1% over the last 7 days, while returns sit at a 2.2% decline over 30 days and a 3.5% decline year to date, with a 16.9% decline over the past year and 19.9% and 20.4% declines across the 3 and 5 year periods respectively.
Recent coverage has focused on U-Haul Holding as a long established name in do it...
Investors may be wondering whether Ituran Location and Control is still priced attractively after a strong run, or if most of the easy gains are already on the table.
The stock last closed at US$51.48, with returns of 5.0% over 7 days, 3.9% over 30 days, 21.1% year to date, 74.1% over 1 year, 179.8% over 3 years and 192.4% over 5 years. This performance may have changed how investors are thinking about risk and reward.
Recent company news has kept Ituran Location and Control in focus for...
Motorola Solutions and T-Mobile announced a partnership to bring satellite and advanced 5G connectivity to APX NEXT radios using Starlink direct-to-cell technology.
The collaboration aims to deliver resilient coverage for first responders, including mission-critical AI features, hands-free SVX devices, and cloud-secured services.
The new capabilities target uninterrupted communication for emergency teams operating outside traditional network areas.
For investors watching NYSE:MSI, this...
Investors may be wondering if Zoom Communications at US$84.02 is offering good value right now, or if the easy money has already been made.
The stock has returned 4.5% over the last 7 days, 8.4% over 30 days, 0.8% year to date and 26.0% over the past year. The 3 year return sits at 20.0%, while the 5 year return reflects a 75.5% decline.
Recent coverage has focused on Zoom's role as a core communications platform and how investors are reassessing long term expectations after the sharp 5 year...
If you are wondering whether Coty is a bargain or a value trap at its recent share price, this article walks through what the numbers are actually saying about the stock.
The share price last closed at US$2.11, with returns of 5.0% over 7 days, an 11.0% decline over 30 days, a 32.2% decline year to date, and a 55.0% decline over 1 year.
That kind of long term share price pressure often lines up with questions about the business outlook and risk. Coty has been in the headlines as investors...
Dorman Products (NasdaqGS:DORM) has appointed President and CEO Kevin Olsen as Chairman of the Board.
Former Chairman Steven Berman will remain on the board following this leadership change.
The move combines the CEO and Chairman roles, signaling a new governance structure for the company.
Dorman Products, which focuses on replacement parts for the automotive aftermarket, now has Kevin Olsen serving as President, CEO and Chairman. For investors, this kind of leadership consolidation can...
Considering whether Cencora’s current share price aligns with its underlying value, or if the market is mispricing the stock.
The stock last closed at US$320.89, with returns of 2.1% over 7 days, a 10.5% decline over 30 days, a 5.3% decline year to date, and 17.6% over 1 year. Together, these figures provide a mixed picture of recent sentiment.
Recent news flow around Cencora has focused on its role within the healthcare supply chain, regulatory scrutiny across the sector, and ongoing...
If you are wondering whether eBay at US$96.01 is offering good value or asking too much, the starting point is to line up its recent performance with what you are actually paying for.
The stock has posted returns of 5.5% over the last week, 3.6% over the last month, 10.3% year to date, 63.6% over the past year, 133.3% over three years, and 64.2% over five years, which naturally raises questions about how much of this is already reflected in the price.
Recent coverage has focused on eBay's...
In March 2026, a lawsuit was filed against Atmos Energy after a Lake Dallas home explosion allegedly linked to a leaking Atmos gas main left resident Jessica Bailey Lopez critically injured and forced the evacuation of her neighborhood.
On the financing side, Atmos Energy has also secured extended maturities on two US$1.50 billion revolving credit facilities, pushing their terms out to 2029 and 2031 and reinforcing its access to liquidity as it manages legal, operational, and infrastructure...
Recent updates show that Texas Roadhouse delivered positive comparable restaurant sales throughout 2025 and early 2026, raised its quarterly dividend, and continues to generate high average unit volumes that rank among the strongest in the U.S. casual dining space.
An interesting angle is that Texas Roadhouse’s large-format restaurants are converting substantial floor space into some of the highest sales volumes in the industry, which helps support its appeal to income-focused investors...
Why Manchester United Stock Is on Investors’ Radar
Without a fresh headline event driving today’s move, interest in Manchester United (NYSE:MANU) is centering on how its recent share performance lines up with fundamentals like revenue, profitability and the current market valuation.
See our latest analysis for Manchester United.
At a share price of US$17.47, Manchester United has a 1 day share price return of about a 1.7% decline. Its year to date share price return of 10.71% and 1 year total...
Texas Capital Bancshares (TCBI) is back in focus after SG Americas Securities LLC cut its stake by 73.7% in the fourth quarter of 2025, prompting fresh attention on the regional bank's fundamentals.
See our latest analysis for Texas Capital Bancshares.
The recent decision by SG Americas Securities to cut its position comes after a period of solid momentum, with the latest share price at $97.58, a year to date share price return of 6.41% and a 1 year total shareholder return of 57.21%...
In recent months, Ameren reported strong Q4 2025 and full-year earnings growth while successfully issuing US$400 million in senior notes and US$450 million in Ameren Missouri mortgage bonds at fixed interest rates of 4.80% and 5.55%.
Together with its ongoing spending on grid upgrades and clean energy, these funding moves emphasize how Ameren is aligning its balance sheet with long-term infrastructure and data center-related power demand.
Now we’ll examine how Ameren’s solid earnings and...
Regulatory milestone for lorundrostat
Mineralys Therapeutics (MLYS) recently reported that the FDA accepted its New Drug Application for lorundrostat in hypertension, while also updating investors on the Explore OSA trial in obstructive sleep apnea.
See our latest analysis for Mineralys Therapeutics.
Mineralys Therapeutics’ share price has pulled back over the past quarter, with a 90 day share price return of 19.92% decline and year to date return of 20.72% decline. However, the 1 year total...
The RealReal recently launched its ‘L’ultimo Uomo Reale (I Am Real)’ ad campaign underscoring its authentication promise, reopened its historic Union Square flagship in San Francisco, and continued investing in authentication operations, including hiring a Senior Manager of Inbound Operations in Phoenix.
Together, these moves highlight how The RealReal is leaning into physical retail, human expertise, and trust-centric messaging as differentiators in the luxury resale market, while also...
Eastern Bankshares (EBC) shares recently reacted to two developments: a Q4 FY25 earnings per share of 0.44 that slightly exceeded expectations, and a leadership change with Jennifer Wambold becoming Chief People Officer.
See our latest analysis for Eastern Bankshares.
The share price has risen 5.06% over the past month and 7.61% year to date. The 1 year total shareholder return of 44.09% and 3 year total shareholder return of 77.44% suggest momentum has been strong over both shorter and...
Insider selling and analyst updates put Privia Health Group (PRVA) in focus
Privia Health Group (PRVA) is back on investor radar after Chief Financial Officer David Mountcastle sold 5,566 shares, followed by a fresh round of analyst updates after the company’s Q4 earnings release.
See our latest analysis for Privia Health Group.
At a share price of $22.38, Privia Health Group has seen short term momentum pick up, with a 1 day share price return of 3.66% and a 7 day share price return of...
Morningstar (MORN) caught fresh attention after expanding the availability of its investment data on Snowflake Marketplace, giving institutional clients broader access to indexes, ESG ratings, credit ratings, and analytics directly within Snowflake environments.
See our latest analysis for Morningstar.
Despite the Snowflake partnership and recent milestones at Morningstar DBRS, Morningstar’s 7 day share price return of 4.5% sits against a weaker backdrop, with a 30 day share price decline of...
Artificial intelligence in healthcare is one of the clearest ways technology meets real world need, especially as higher energy prices, geopolitical tension, and sticky inflation keep pressure on costs and productivity. While many sectors face softer activity and rising input prices, AI tools that support better diagnostics, smoother hospital operations, and faster drug discovery speak directly to efficiency and outcomes. This screener focuses on companies applying AI to these problems,...
